Over the last two years, Botox has emerged as one of the possible remedies for treating premature ejaculation (PE). This has been the result of a much-publicized study carried out researchers at the University of Tulane in 2014. This study found Botox to be effective for delaying ejaculation in rats. (Source: http://www.ncbi.nlm.nih.gov/pubmed/24774776)
In the study, male rats had Botox injected into their bulbospongiosus muscle. This muscle is located in the penis and controls erection, ejaculation and orgasm. The human penis contains an analogous muscle. When the rats were injected with Botox, the amount of time they took to ejaculate jumped from 6.5 minutes to 8.5 and 10 minutes (depending on the amount of Botox).
This caused some people to conclude that Botox has could have similar effects on humans. After all, the human penis has the bulbospongiosus muscle – just like the rat penis. Also, Botox is already used to safely treat sexual dysfunctions like vaginismus. So, why not use it to help men who want to last longer in bed?
No Human Trials Yet
Well, the most compelling reason is that Botox hasn’t yet been successfully tested on humans for treating premature ejaculation. Simply because it works on rats doesn’t mean that it will work on humans. Also, simply because Botox helps with wrinkles, migraines and vaginismus doesn’t mean that it can help with premature ejaculation.
The simple fact that human trials haven’t been carried out means that there could be harmful effects which are yet unknown. So, at this stage, using Botox for treating premature ejaculation is a huge gamble. A smarter approach would wait for the results from human trials.
Human trials are currently being carried out by ClinicalTrials.gov – a branch of the U.S. National Institutes of Health. The trials – which commenced in 2013 – are investigating the effectiveness and safety of Botox for treating premature ejaculation. Preliminary results are expected to be released in October 2016.
Until then, it would be unwise to use Botox for treating premature ejaculation. The good news is that ClinicalTrials.gov is actually still recruiting volunteers. So those who desire to try out Botox in a safe environment can sign up for the clinical trials. Whoever desires to sign up should visit this page (https://clinicaltrials.gov/ct2/show/NCT01917006)
Risk of Lowering Libido?
In rats, Botox was found to reduce the frequency of mounting. On average, the rats which weren’t receiving botox mounted 11.5 times. Those on Botox mounted 7 – 8 times on average within the same time period. This basically means that the rats on Botox were mounting 30 to 40% less than their normal counterparts.
Does this mean that Botox reduced their sexual drive? Possibly. The researchers didn’t give conclusive explanations. However, the consensus was that Botox was likely reducing the sexual desires of the rats.
What does this mean for humans? Well, it means that – if Botox has a similar effect as on rats – then it could end up lowering libido. Lowering someone’s libido by 30 to 40% would be disastrous. Despite the fact that this is merely speculative, it just points to the possible side-effects of Botox. Those who use it to last longer in bed might ironically find themselves losing sexual desire. This would be a travesty.
When used for treating premature ejaculation, Botox is supposed to be injected into the bulbospongiosus muscle. In humans, this muscle starts between the rectum and penis, and runs to the underside of the penis. To administer the Botox, an injection would have to be made to the underside of the penis.
Now, anyone who has ever received an injection anywhere around the groin knows that it can be extremely painful. However, the pain is nothing compared to that which occurs during erection. People who have experienced injury to their bulbospongiosus usually feel excruciating pain during erection.
This means that in the immediate aftermath of the Botox injection, a person would have to steer clear of sexually arousing situations. This means that immediately after taking the Botox injection, a person would be forced to abstain.
Risk of Infections
Actually, pain maybe the least worry for those receiving Botox injections (after all, pain killers do exist). An even greater worry is the risk of infections. There are two kinds of infections which an injection to the lower side of the penis can expose someone to.
The first is from bacteria which is typically found around the pelvic area. This bacteria can easily make their way into the little cut which is left by the injection. This can cause it to become infected, inflamed and quite uncomfortable.
An even worse kind of infection can arise from having unprotected intercourse. Any cut on the penis typically multiplies the risk of acquiring sexually transmitted infections. As such, if the person has intercourse with someone with such an infection, they can significantly increase their risks.
Even those who use protective measures like condoms aren’t entirely safe. The friction which arises from vigorous sexual activity can cause further bruising of the injected area. This is because the heat generated from wearing a condom can intensify during sexual intercourse. In the end, this can lead to a larger bruise, which is even more susceptible to infection.
The Bottom Line
The bottom line is that Botox may seem like the perfect solution for someone seeking to last longer in bed. After all, it has been tested on rats and been found to work perfectly. Also, Botox is currently used safely for treating a number of conditions such as vaginismus, migraines, bladder dysfunction and cervical dystonia.
However, there haven’t been any successful human trials on the use of Botox for treating premature ejaculation. As such, those who use it will be exposing themselves to excruciating pain, infections and possible loss of libido. That is before even considering the yet unknown side-effects. Essentially, such people are taking unnecessary risks.
Therefore, a smarter approach is to wait until human trials have produced concrete results. Thankfully, the trials are currently being carried out by ClinicalTrials.gov. The trials are still recruiting volunteers in 5 US states (New York, Louisiana, Florida, Connecticut and California) and in London, UK.